Novo Nordisk CEO Looks Beyond Weight Loss to Longevity, Aesthetics
Novo Nordisk A/S Chief Executive Officer Mike Doustdar says the company’s blockbuster obesity drugs could ultimately pull it…
European Carmakers Lobby Brussels for Flexibility on Emissions Rules
Welcome to the Brussels Edition. I’m Suzanne Lynch, Bloomberg’s Brussels bureau chief, bringing you the latest from the…
Our Lego Agency’s Jennifer Berry on Building Connected Commerce Beyond Channels
Our Lego Agency’s Jennifer Berry on Building Connected Commerce Beyond Channels In this episode of Brave Commerce, Rachel…
Novo Says Priority Is Obesity Despite Investor Calls to Expand
Novo Nordisk A/S is doubling down on obesity and diabetes, putting it at loggerheads with investors calling for…